title: Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer.
authors.affiliation: Dana Farber Cancer Institute, Boston, MA 02115, USA. robert_haddad@dfci.harvard.edu
authors.forename: Robert
authors.initials: R
authors.lastname: Haddad
authors.forename: Anand
authors.initials: A
authors.lastname: Mahadevan
authors.forename: Marshall R
authors.initials: MR
authors.lastname: Posner
authors.forename: Christopher
authors.initials: C
authors.lastname: Sullivan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D013964:Thyroid Neoplasms / Q000628:therapy*; D013965:Thyroidectomy
chemical_list: D016190:Carboplatin; D017239:Paclitaxel